Options Brief: Cytori Therapeutics (CYTX)
Shares of Cytori Therapeutics (NASDAQ: CYTX) are higher on the session by 2.30%, trading at $6.67.
Overall call volume is now running at 2.09x the daily average, with 64% of all calls traded being purchases on the offer. 1,534 contracts have traded on the session so far.
Cytori Therapeutics, Inc. develops, manufactures, and sells medical products and devices to enable the practice of regenerative medicine. The company's technology is the Celuion family of products, which processes patients' adipose-derived stem and regenerative cells (ADRCs) at the point of care.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.